|
HY-100128-10mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100128-100mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100128-25mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100128-5mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100128-50mg
|
MedChemexpress LLC
|
DM1-SMe [CAS 138148-68-2]
|
|
Cancer-programmed cell death
|
|
|
HY-106161-1mg
|
MedChemexpress LLC
|
Rupintrivir [CAS 223537-30-2]
|
|
COVID-19-anti-virus
|
|
|
HY-106161-10mg
|
MedChemexpress LLC
|
Rupintrivir [CAS 223537-30-2]
|
|
COVID-19-anti-virus
|
|
|
HY-106161-5mg
|
MedChemexpress LLC
|
Rupintrivir [CAS 223537-30-2]
|
|
COVID-19-anti-virus
|
|
|
HY-122639-10mg
|
MedChemexpress LLC
|
ZINC05007751 [CAS 591239-68-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-122639-100mg
|
MedChemexpress LLC
|
ZINC05007751 [CAS 591239-68-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-122639-25mg
|
MedChemexpress LLC
|
ZINC05007751 [CAS 591239-68-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-122639-5mg
|
MedChemexpress LLC
|
ZINC05007751 [CAS 591239-68-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-122639-50mg
|
MedChemexpress LLC
|
ZINC05007751 [CAS 591239-68-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-12501-10mg
|
MedChemexpress LLC
|
ITI-214 (free base) [CAS 1160521-50-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501-5mg
|
MedChemexpress LLC
|
ITI-214 (free base) [CAS 1160521-50-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501-50mg
|
MedChemexpress LLC
|
ITI-214 (free base) [CAS 1160521-50-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-10mg
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-5mg
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12501A-50mg
|
MedChemexpress LLC
|
ITI-214 [CAS 1642303-38-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-125331-10mg
|
MedChemexpress LLC
|
DRF-1042 [CAS 200619-13-2]
|
|
Cancer-programmed cell death
|
|
|
HY-125331-100mg
|
MedChemexpress LLC
|
DRF-1042 [CAS 200619-13-2]
|
|
Cancer-programmed cell death
|
|
|
HY-125331-25mg
|
MedChemexpress LLC
|
DRF-1042 [CAS 200619-13-2]
|
|
Cancer-programmed cell death
|
|
|
HY-125331-5mg
|
MedChemexpress LLC
|
DRF-1042 [CAS 200619-13-2]
|
|
Cancer-programmed cell death
|
|
|
HY-125331-50mg
|
MedChemexpress LLC
|
DRF-1042 [CAS 200619-13-2]
|
|
Cancer-programmed cell death
|
|
|
HY-144898-10mg
|
MedChemexpress LLC
|
SB-216 [CAS 2756818-39-8]
|
|
Cancer-programmed cell death
|
|
